학술논문
Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
Document Type
article
Author
Source
Ophthalmology and Therapy, Vol 9, Iss 4, Pp 913-915 (2020)
Subject
Language
English
ISSN
2193-8245
2193-6528
2193-6528
Abstract
The authors of the above mentioned article would like to highlight the following corrections, based upon recent changes to the FDA label and guidance on the use of belamaf